All 2022 SCM presentations
View another way?![](//assets.vl.aapm.org/vl/2022/SCM/0-16424-Pavord.jpg)
SA-A-Celestin AAPM Medical Physics Practice Guidelines
AAPM Medical Physics Practice GuidelinesPresented by Daniel Pavord, Allegheny General Hospital
This presentation has an average satisfaction 4.5 (higher is better), with 4 responding
VLID: 16424
![](//assets.vl.aapm.org/vl/2022/SCM/0-16425-Olch.jpg)
SA-A-Celestin AAPM Medical Physics Practice Guidelines
Update On Therapy MPPGsPresented by Arthur Olch, Childrens Hospital of LA
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 16425
![](//assets.vl.aapm.org/vl/2022/SCM/0-16426-Keenan.jpg)
SA-A-Celestin AAPM Medical Physics Practice Guidelines
Update On Imaging MPPGsPresented by Mary Keenan, Vanderbilt University Medical Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16426
![](//assets.vl.aapm.org/vl/2022/SCM/0-16407-Kavanaugh.jpg)
SA-C-Celestin Practical Considerations for the Clinical Physicist
Enhancing a Physicist's Role in the Assessment of Treatment Plan QualityPresented by James Kavanaugh, Washington University in St. Louis
This presentation has an average satisfaction 4.7 (higher is better), with 3 responding
VLID: 16407
![](//assets.vl.aapm.org/vl/2022/SCM/0-16408-Lin.jpg)
SA-C-Celestin Practical Considerations for the Clinical Physicist
Enhancing a Physicist's Role in the Assessment of Treatment Plan QualityPresented by Mu-Han Lin, The University of Texas Southwestern Medical Ctr
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 16408
![](//assets.vl.aapm.org/vl/2022/SCM/0-16409-Draeger.jpg)
SA-C-Celestin Practical Considerations for the Clinical Physicist
Superficial Targets: Do I Use Photons, Electrons or Brachytherapy?Presented by Emily Draeger, Yale New Haven Hospital
This presentation has an average satisfaction 5.0 (higher is better), with 3 responding
VLID: 16409
![](//assets.vl.aapm.org/vl/2022/SCM/0-16410-Hogstrom.jpg)
SA-C-Celestin Practical Considerations for the Clinical Physicist
Superficial Targets: Do I Use Photons, Electrons or Brachytherapy?Presented by Kenneth Hogstrom, Mary Bird Perkins Cancer Center
This presentation has an average satisfaction 4.5 (higher is better), with 2 responding
VLID: 16410
![](//assets.vl.aapm.org/vl/2022/SCM/0-16411-Shi.jpg)
SA-C-Celestin Practical Considerations for the Clinical Physicist
Are You Ready When Patients Undergoing Radiotherapy Have Such Implanted Devices?Presented by Chengyu Shi, New York Proton Center
This presentation has an average satisfaction 5.0 (higher is better), with 3 responding
VLID: 16411
![](//assets.vl.aapm.org/vl/2022/SCM/0-16412-Chan.jpg)
SA-C-Celestin Practical Considerations for the Clinical Physicist
Are You Ready When Patients Undergoing Radiotherapy Have Such Implanted Devices?Presented by Maria Chan, Memorial Sloan Kettering Cancer Center
This presentation has an average satisfaction 4.7 (higher is better), with 3 responding
VLID: 16412
![](//assets.vl.aapm.org/vl/2022/SCM/0-16420-Olguin.jpg)
SA-C-Imperial CTDIvol - The Helical Revolution?
Overcoming Clinical Challenges in Measuring CTDIvolPresented by Edmond Olguin
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 16420
![](//assets.vl.aapm.org/vl/2022/SCM/0-16421-Gress.jpg)
SA-C-Imperial CTDIvol - The Helical Revolution?
How Changes Can Happen in ACR AccredidationPresented by Dustin Gress, American College of Radiology
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 16421
![](//assets.vl.aapm.org/vl/2022/SCM/0-16422-Aufdemberge.jpg)
SA-C-Imperial CTDIvol - The Helical Revolution?
Challenges in Traditional Axial CTDIvol Measurements Eliminated with the Proposed Helical CTDIvol MethodPresented by Thomas Aufdemberge, Medical Physics Consultants
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 16422
![](//assets.vl.aapm.org/vl/2022/SCM/0-16414-Huber.jpg)
SA-D-Celestin Radiation Timing: The Physician & Physicist Perspective
Radiobiological and Clinical Principles That Guide Treatment Schedule ChangesPresented by Kathryn Huber, Tufts Medical Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16414
![](//assets.vl.aapm.org/vl/2022/SCM/0-16415-Taylor.jpg)
SA-D-Celestin Radiation Timing: The Physician & Physicist Perspective
Practical Approaches to Documenting Accumulation From Multiple and Missed TreatmentsPresented by Michael Taylor, Alliance Cancer Care
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 16415
![](//assets.vl.aapm.org/vl/2022/SCM/0-16416-Q&A.jpg)
SA-D-Celestin Radiation Timing: The Physician & Physicist Perspective Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16416
![](//assets.vl.aapm.org/vl/2022/SCM/0-16417-Rosado-Mendez.jpg)
SA-D-Imperial Carson-Zagzebski Distinguished Lectureship On QIBA Profiles in Ultrasound
US QIBA - Pulse Echo Quantitative US Parameters (PEQUS) and Shear Wave Speed (SWS)Presented by Ivan Rosado-Mendez, University of Wisconsin-Madison
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 16417
![](//assets.vl.aapm.org/vl/2022/SCM/0-16418-Carson.jpg)
SA-D-Imperial Carson-Zagzebski Distinguished Lectureship On QIBA Profiles in Ultrasound
US QIBA - Volume Blood Flow (VBF) and Contrast Enhanced US (CEUS)Presented by Paul Carson, The University of Michigan Health System
This presentation has an average satisfaction 3.0 (higher is better), with 1 responding
VLID: 16418
![](//assets.vl.aapm.org/vl/2022/SCM/0-16430-Tracy.jpg)
SA-SHOWCASE-Celestin Sun Nuclear Corporation
Improving Patient Safety through Standardized, Automated Quality Management for Standard & SRS TreatmentsPresented by Jason Tracy, Sun Nuclear Corporation
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16430
![](//assets.vl.aapm.org/vl/2022/SCM/0-16431-Q&A.jpg)
SA-SHOWCASE-Celestin Sun Nuclear Corporation Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16431
![](//assets.vl.aapm.org/vl/2022/SCM/0-16443-Cai.jpg)
SU-A-Celestin 18F-DOPA PET/CT for Radiation Treatment Planning and Prognostication in Patients With High-Grade Glioma
Radiochemist Perspective On 18F-DOPA-Directed Radiotherapy for High-Grade GliomaPresented by Hancheng Cai, Mayo Clinic
This presentation has an average satisfaction 5.0 (higher is better), with 2 responding
VLID: 16443
![](//assets.vl.aapm.org/vl/2022/SCM/0-16444-Breen.jpg)
SU-A-Celestin 18F-DOPA PET/CT for Radiation Treatment Planning and Prognostication in Patients With High-Grade Glioma
Clinical Perspectives On 18F-DOPA-Directed Radiotherapy for High-Grade Glioma: Early Data, Utility, and Future DirectionsPresented by William Breen, Mayo Clinic
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 16444
![](//assets.vl.aapm.org/vl/2022/SCM/0-16445-Qian.jpg)
SU-A-Celestin 18F-DOPA PET/CT for Radiation Treatment Planning and Prognostication in Patients With High-Grade Glioma
Prediction of Treatment Prognosis and Tumor Aggressiveness Based On Radiomics and FDOPA PET Images for Newly Diagnosed Glioblastoma Treated with Escalated Radiation DosePresented by Jing Qian, Mayo Clinic
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 16445
![](//assets.vl.aapm.org/vl/2022/SCM/0-16446-Q&A.jpg)
SU-A-Celestin 18F-DOPA PET/CT for Radiation Treatment Planning and Prognostication in Patients With High-Grade Glioma Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16446
![](//assets.vl.aapm.org/vl/2022/SCM/0-16462-Thomadsen.jpg)
SU-B-Celestin Causal Analysis
How To Perform a Causal AnalysisPresented by Bruce Thomadsen, University of Wisconsin
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16462
![](//assets.vl.aapm.org/vl/2022/SCM/0-16463-Kim.jpg)
SU-B-Celestin Causal Analysis
The Challenges and Barriers for Causal AnalysisPresented by Grace Gwe-Ya Kim, University of California, San Diego
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16463
![](//assets.vl.aapm.org/vl/2022/SCM/0-16464-Buckey.jpg)
SU-B-Celestin Causal Analysis
Moving Forward: Remediating Errors and Preventing New OnesPresented by Courtney Buckey, Mayo Clinic Arizona
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16464
![](//assets.vl.aapm.org/vl/2022/SCM/0-16465-Q&A.jpg)
SU-B-Celestin Causal Analysis Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16465
![](//assets.vl.aapm.org/vl/2022/SCM/0-16449-Walz-Flannigan.jpg)
SU-B-Imperial Monitoring the Monitors
Monitoring the MonitorsPresented by Alisa Walz-Flannigan, Marshfield Clinic
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16449
![](//assets.vl.aapm.org/vl/2022/SCM/0-16450-Xthona.jpg)
SU-B-Imperial Monitoring the Monitors
Barco Tools for Monitor QCPresented by Albert Xthona, Barco
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16450
![](//assets.vl.aapm.org/vl/2022/SCM/0-16451-Snyder.jpg)
SU-B-Imperial Monitoring the Monitors
Atirix Fleet Management ToolPresented by Angela Snyder, Atirix Medical Systems, Inc
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16451
![](//assets.vl.aapm.org/vl/2022/SCM/0-16452-Dodge.jpg)
SU-B-Imperial Monitoring the Monitors
Roundtable DiscussionPresented by Cristina Dodge, AdventHealth
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16452
![](//assets.vl.aapm.org/vl/2022/SCM/0-16453-Q&A.jpg)
SU-B-Imperial Monitoring the Monitors Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16453
![](//assets.vl.aapm.org/vl/2022/SCM/0-16432-Hoisak.jpg)
SU-C-Celestin Practical Improvements: Make It Go Away or Make It Better
Shortening the Sim-to-Start WindowPresented by Jeremy Hoisak, UC San Diego
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16432
![](//assets.vl.aapm.org/vl/2022/SCM/0-16433-Kerns.jpg)
SU-C-Celestin Practical Improvements: Make It Go Away or Make It Better
3D Printing makes everything better, including Machine QAPresented by James Kerns
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16433
![](//assets.vl.aapm.org/vl/2022/SCM/0-16434-Krauss.jpg)
SU-C-Celestin Practical Improvements: Make It Go Away or Make It Better
Innovations in Linac Quality AssurancePresented by Robert Krauss, St. Francis Hospital
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16434
![](//assets.vl.aapm.org/vl/2022/SCM/0-16435-Roberts.jpg)
SU-C-Celestin Practical Improvements: Make It Go Away or Make It Better
Quality Assurance for Multi-Target Stereotactic RadiosurgeryPresented by Donald Roberts, University of Michigan Hospital
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16435
![](//assets.vl.aapm.org/vl/2022/SCM/0-16436-Q&A.jpg)
SU-C-Celestin Practical Improvements: Make It Go Away or Make It Better Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16436
![](//assets.vl.aapm.org/vl/2022/SCM/0-16454-Gress.jpg)
SU-C-Imperial The Modern Practice of Professional Diagnostic Physics
Diagnostic Workforce IPresented by Dustin Gress, American College of Radiology
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16454
![](//assets.vl.aapm.org/vl/2022/SCM/0-16455-Rose.jpg)
SU-C-Imperial The Modern Practice of Professional Diagnostic Physics
Diagnostic Workforce IIPresented by Sean Rose, University of Texas at Houston Medical School
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16455
![](//assets.vl.aapm.org/vl/2022/SCM/0-16456-Wilson.jpg)
SU-C-Imperial The Modern Practice of Professional Diagnostic Physics
Diagnostic Practice ModelsPresented by Joshua Wilson, Duke University Health System
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16456
![](//assets.vl.aapm.org/vl/2022/SCM/0-16457-Gauntt.jpg)
SU-C-Imperial The Modern Practice of Professional Diagnostic Physics
Diagnostic Practice ModelsPresented by David Gauntt, UAB Medical Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16457
![](//assets.vl.aapm.org/vl/2022/SCM/0-16458-Milman.jpg)
SU-C-Imperial The Modern Practice of Professional Diagnostic Physics
Diagnostic Practice ModelsPresented by Rebecca Milman, University of Colorado School of Medicine
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16458
![](//assets.vl.aapm.org/vl/2022/SCM/0-16459-Fisher.jpg)
SU-C-Imperial The Modern Practice of Professional Diagnostic Physics
Diagnostic Practice ModelsPresented by Ryan Fisher, MetroHealth
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16459
![](//assets.vl.aapm.org/vl/2022/SCM/0-16438-Pankuch.jpg)
SU-D-Celestin Advancing Particle Therapy in the United States
A Decade of Scanning Beam Proton Therapy in The United StatesPresented by Mark Pankuch, Northwestern Medicine Chicago Proton Center
This presentation has an average satisfaction 5.0 (higher is better), with 4 responding
VLID: 16438
![](//assets.vl.aapm.org/vl/2022/SCM/0-16439-Mascia.jpg)
SU-D-Celestin Advancing Particle Therapy in the United States
Deploying FLASH Radiotherapy in a Clinical Trial SettingPresented by Anthony Mascia, University of Cincinnati Medical Center
This presentation has an average satisfaction 4.0 (higher is better), with 2 responding
VLID: 16439
![](//assets.vl.aapm.org/vl/2022/SCM/0-16440-Beltran.jpg)
SU-D-Celestin Advancing Particle Therapy in the United States
Carbon IonsPresented by Chris Beltran, Mayo Clinic
This presentation has an average satisfaction 4.0 (higher is better), with 2 responding
VLID: 16440
![](//assets.vl.aapm.org/vl/2022/SCM/0-16442-Q&A.jpg)
SU-D-Celestin Advancing Particle Therapy in the United States Q & A
Q & APresented by
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 16442
![](//assets.vl.aapm.org/vl/2022/SCM/0-16447-Bevins.jpg)
SU-D-Imperial Spotlight on Mammography QC Transition
Alternative Standard Implementation: Experiences From Transitioning a Large Health Care System to the ACR Digital Mammography Quality ControlPresented by Nicholas Bevins, Henry Ford Health System
This presentation has an average satisfaction 5.0 (higher is better), with 2 responding
VLID: 16447
![](//assets.vl.aapm.org/vl/2022/SCM/0-16448-Q&A.jpg)
SU-D-Imperial Spotlight on Mammography QC Transition Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16448
![](//assets.vl.aapm.org/vl/2022/SCM/0-16466-Matney.jpg)
MO-A-Celestin Brachy: Basics to Advancements
Back to Brachy BasicsPresented by Jason Matney, UC Davis Cancer Center
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 16466
![](//assets.vl.aapm.org/vl/2022/SCM/0-16467-Simiele.jpg)
MO-A-Celestin Brachy: Basics to Advancements
Image-Guided Prostate Brachytherapy: A US, MR, and CT-Based LDR WorkflowPresented by Samantha Simiele, MD Anderson Cancer Center
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 16467
![](//assets.vl.aapm.org/vl/2022/SCM/0-16468-Besemer.jpg)
MO-A-Celestin Brachy: Basics to Advancements
Image-Guided Prostate Brachytherapy: A US/MR-Based HDR WorkflowPresented by Abby Besemer, University of Nebraska Medical Center
This presentation has an average satisfaction 5.0 (higher is better), with 4 responding
VLID: 16468
![](//assets.vl.aapm.org/vl/2022/SCM/0-16469-Prisciandaro.jpg)
MO-A-Celestin Brachy: Basics to Advancements
Clinical Implementation of MRI for Gynecologic and Prostate HDR BrachytherapyPresented by Joann Prisciandaro, University of Michigan
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 16469
![](//assets.vl.aapm.org/vl/2022/SCM/0-16470-Cohen.jpg)
MO-A-Celestin Brachy: Basics to Advancements
Clinical Implementation of MRI for Gynecologic and Prostate HDR BrachytherapyPresented by Gil'ad Cohen, Memorial Sloan-Kettering Cancer Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16470
![](//assets.vl.aapm.org/vl/2022/SCM/0-16471-Craciunescu.jpg)
MO-A-Celestin Brachy: Basics to Advancements
Developing Modern Brachytherapy Teaching ToolsPresented by Oana Craciunescu, Duke University Medical Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16471
![](//assets.vl.aapm.org/vl/2022/SCM/0-16472-Li.jpg)
MO-A-Celestin Brachy: Basics to Advancements
Developing Modern Brachytherapy Teaching ToolsPresented by Taoran Li, University of Pennsylvania
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16472
![](//assets.vl.aapm.org/vl/2022/SCM/0-16473-Q&A.jpg)
MO-A-Celestin Brachy: Basics to Advancements Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16473
![](//assets.vl.aapm.org/vl/2022/SCM/0-16491-Mahmood.jpg)
MO-A-Imperial Advances and Applications of AI in Pediatric Radiology
Five Questions to Ask AI Vendors – What You Need to Know Before You BuyPresented by Usman Mahmood, Memorial Sloan Kettering Cancer Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16491
![](//assets.vl.aapm.org/vl/2022/SCM/0-16492-Brady.jpg)
MO-A-Imperial Advances and Applications of AI in Pediatric Radiology
Practical Tips and Advice After Implementing AI Technologies in the ClinicPresented by Samuel Brady, Cincinnati Childrens Hospital Med Ctr
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16492
![](//assets.vl.aapm.org/vl/2022/SCM/0-16493-Q&A.jpg)
MO-A-Imperial Advances and Applications of AI in Pediatric Radiology Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16493
![](//assets.vl.aapm.org/vl/2022/SCM/0-16474-Zheng.jpg)
MO-B-Celestin Learn From Those Who've Been There Before: Clinical Implementation of Procedures and Technologies
Quick Start Guide to New Procedures and Technologies in RadiotherapyPresented by Dandan Zheng, University of Rochester
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 16474
![](//assets.vl.aapm.org/vl/2022/SCM/0-16475-Tanny.jpg)
MO-B-Celestin Learn From Those Who've Been There Before: Clinical Implementation of Procedures and Technologies
Quick Start Guide to New Procedures and Technologies in RadiotherapyPresented by Sean Tanny, University of Rochester
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 16475
![](//assets.vl.aapm.org/vl/2022/SCM/0-16476-Ruiz.jpg)
MO-B-Celestin Learn From Those Who've Been There Before: Clinical Implementation of Procedures and Technologies
Experience with Clinical Implementation of the Halcyon: Lessons Learned for the Practicing PhysicistPresented by Brian Ruiz, Beaufort Memorial Hospital (Alliance Oncology)
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 16476
![](//assets.vl.aapm.org/vl/2022/SCM/0-16477-Ulizio.jpg)
MO-B-Celestin Learn From Those Who've Been There Before: Clinical Implementation of Procedures and Technologies
Experience with Clinical Implementation of the Halcyon: Lessons Learned for the Practicing PhysicistPresented by Vincent Ulizio, Alliance Cancer Care
This presentation has an average satisfaction 3.5 (higher is better), with 2 responding
VLID: 16477
![](//assets.vl.aapm.org/vl/2022/SCM/0-16478-Grams.jpg)
MO-B-Celestin Learn From Those Who've Been There Before: Clinical Implementation of Procedures and Technologies
Clinical Implementation and Utilization of Spatially Fractionated Radiation TherapyPresented by Michael Grams, Mayo Clinic
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 16478
![](//assets.vl.aapm.org/vl/2022/SCM/0-16479-Q&A.jpg)
MO-B-Celestin Learn From Those Who've Been There Before: Clinical Implementation of Procedures and Technologies Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16479
![](//assets.vl.aapm.org/vl/2022/SCM/0-16488-Williams.jpg)
MO-B-Imperial Breast Biopsy: Clinical Physicist Perspectives
What Do I Do Now? Vendor QC Requirements for Upright AttachmentsPresented by Carly Williams, Radiation Services, Inc.
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16488
![](//assets.vl.aapm.org/vl/2022/SCM/0-16489-Edmonson.jpg)
MO-B-Imperial Breast Biopsy: Clinical Physicist Perspectives
MR Safety in Breast Imaging and MR-Guided Breast BiopsyPresented by Heidi Edmonson, Mayo Clinic
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16489
![](//assets.vl.aapm.org/vl/2022/SCM/0-16490-Q&A.jpg)
MO-B-Imperial Breast Biopsy: Clinical Physicist Perspectives Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16490
![](//assets.vl.aapm.org/vl/2022/SCM/0-16496-Applegate.jpg)
MO-C-Celestin Ethics for the Medical Physicist: Updates and Discussions from the ICRP and AAPM Task Groups
Teaching and Harmonizing Radiological Protection Ethics in MedicinePresented by Kimberly Applegate
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16496
![](//assets.vl.aapm.org/vl/2022/SCM/0-16497-Fahey.jpg)
MO-C-Celestin Ethics for the Medical Physicist: Updates and Discussions from the ICRP and AAPM Task Groups
Teaching and Harmonizing Radiological Protection Ethics in MedicinePresented by Frederic Fahey, Children's Hospital
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16497
![](//assets.vl.aapm.org/vl/2022/SCM/0-16498-St-Aubin.jpg)
MO-C-Celestin Ethics for the Medical Physicist: Updates and Discussions from the ICRP and AAPM Task Groups
Ethics Unwrapped: Ethics Case Study in Social Media UsePresented by Joel St-Aubin, University of Iowa
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16498
![](//assets.vl.aapm.org/vl/2022/SCM/0-16499-Castillo.jpg)
MO-C-Celestin Ethics for the Medical Physicist: Updates and Discussions from the ICRP and AAPM Task Groups
Ethics Unwrapped: Ethics Case Study in Social Media UsePresented by Richard Castillo, Emory Univ
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16499
![](//assets.vl.aapm.org/vl/2022/SCM/0-16481-Kim.jpg)
MO-D-Celestin Implementing Novelties in the Clinic
Multiple Brain Metastases Stereotactic RadiosurgeryPresented by Grace Gwe-Ya Kim, University of California, San Diego
This presentation has an average satisfaction 3.7 (higher is better), with 3 responding
VLID: 16481
![](//assets.vl.aapm.org/vl/2022/SCM/0-16482-Gu.jpg)
MO-D-Celestin Implementing Novelties in the Clinic
Multiple Brain Metastases Stereotactic RadiosurgeryPresented by Xuejun Gu, Stanford University
This presentation has an average satisfaction 3.7 (higher is better), with 3 responding
VLID: 16482
![](//assets.vl.aapm.org/vl/2022/SCM/0-16484-Galavis.jpg)
MO-D-Celestin Implementing Novelties in the Clinic
Clinical Implementation of VMAT Total Body IrradiationPresented by Paulina Galavis, NYU Langone Medical Center
This presentation has an average satisfaction 3.7 (higher is better), with 3 responding
VLID: 16484
![](//assets.vl.aapm.org/vl/2022/SCM/0-16485-Teruel.jpg)
MO-D-Celestin Implementing Novelties in the Clinic
Clinical Implementation of VMAT Total Body IrradiationPresented by Jose Teruel, NYU Langone Health
This presentation has an average satisfaction 4.2 (higher is better), with 5 responding
VLID: 16485
![](//assets.vl.aapm.org/vl/2022/SCM/0-16487-Q&A.jpg)
MO-D-Celestin Implementing Novelties in the Clinic Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16487
![](//assets.vl.aapm.org/vl/2022/SCM/0-16494-Brunnquell.jpg)
MO-D-Imperial MR Homogeneity: Introduction and Vendor-Specific Evaluation
MR Homogeneity: Introduction and Vendor-Specific EvaluationPresented by Christina Brunnquell, University of Washington
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16494
![](//assets.vl.aapm.org/vl/2022/SCM/0-16495-Q&A.jpg)
MO-D-Imperial MR Homogeneity: Introduction and Vendor-Specific Evaluation Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16495
![](//assets.vl.aapm.org/vl/2022/SCM/0-16501-Stanley.jpg)
TU-A-Celestin Do We Have a Plan B? Adaptive Therapy
Clinical Implementation of Adaptive TherapyPresented by Dennis Stanley, The University of Alabama at Birmingham
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 16501
![](//assets.vl.aapm.org/vl/2022/SCM/0-16502-Price.jpg)
TU-A-Celestin Do We Have a Plan B? Adaptive Therapy
Building An Adaptive Radiotherapy Program From An MR and CT Based PerspectivePresented by Alex Price, Washington University in St. Louis
This presentation has an average satisfaction 4.0 (higher is better), with 2 responding
VLID: 16502
![](//assets.vl.aapm.org/vl/2022/SCM/0-16503-Tanny.jpg)
TU-A-Celestin Do We Have a Plan B? Adaptive Therapy
Clinical Implementation of CBCT-Guided Online Adaptive TherapyPresented by Sean Tanny, University of Rochester
This presentation has an average satisfaction 3.0 (higher is better), with 1 responding
VLID: 16503
![](//assets.vl.aapm.org/vl/2022/SCM/0-16504-Rong.jpg)
TU-A-Celestin Do We Have a Plan B? Adaptive Therapy
Consideration of Treatment Accuracy, Efficiency, and Cost with the Overall Impact of RO-APMPresented by Yi Rong, Mayo Clinic Arizona
This presentation has an average satisfaction 3.0 (higher is better), with 2 responding
VLID: 16504
![](//assets.vl.aapm.org/vl/2022/SCM/0-16505-Q&A.jpg)
TU-A-Celestin Do We Have a Plan B? Adaptive Therapy Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16505
![](//assets.vl.aapm.org/vl/2022/SCM/0-16506-Pisano.jpg)
TU-A-Imperial A Different Angle on Tomosynthesis: Clinical Use and Evaluation
TMIST - A Bridge to Individualized Breast Cancer ScreeningPresented by Etta Pisano, American College of Radiology
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 16506
![](//assets.vl.aapm.org/vl/2022/SCM/0-16507-Ikejimba.jpg)
TU-A-Imperial A Different Angle on Tomosynthesis: Clinical Use and Evaluation
Performance of Digital Breast Tomosynthesis: Where Are We Now?Presented by Lynda Ikejimba, Malcova LLC
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16507
![](//assets.vl.aapm.org/vl/2022/SCM/0-16508-Q&A.jpg)
TU-A-Imperial A Different Angle on Tomosynthesis: Clinical Use and Evaluation Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16508
![](//assets.vl.aapm.org/vl/2022/SCM/0-16509-Martin.jpg)
TU-B-Celestin Legislative and Regulatory Update
Legislative and Regulatory UpdatePresented by Richard Martin, AAPM
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16509
![](//assets.vl.aapm.org/vl/2022/SCM/0-16510-Reiter.jpg)
TU-B-Celestin Legislative and Regulatory Update
Legislative OutlookPresented by Matt Reiter, Capital Associates, Inc.
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 16510
![](//assets.vl.aapm.org/vl/2022/SCM/0-16511-Elee.jpg)
TU-B-Celestin Legislative and Regulatory Update
CRCPD UpdatePresented by Jennifer Elee, LA Dept of Environmental Qual
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16511
![](//assets.vl.aapm.org/vl/2022/SCM/0-16512-Q&A.jpg)
TU-B-Celestin Legislative and Regulatory Update Q & A
Q & APresented by
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 16512